Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment

Cell Research

Volumn 25, Issue 5, 2015, Pages 588-603

  Li, Pu ^a   Shan, Jing Xuan ^c   Chen, Xue Hua ^a   Zhang, Di ^b   Su, Li Ping ^a   Huang, Xiu Ying ^b   Yu, Bei Qin ^a   Zhi, Qiao Ming ^a   Li, Cheng Long ^a   Wang, Ya Qing ^b   Tomei, Sara ^c   Cai, Qu ^a   Ji, Jun ^a   Li, Jian Fang ^a   Chouchane, Lotfi ^c   Yu, Ying Yan ^a   Sun, Fang Zhen ^b   Xu, Zhi Heng ^b   Liu, Bing Ya ^a   Zhu, Zheng Gang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^c WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

cancer associated fibroblasts; epigenetic silencing; IL 6; microRNA 149; PGE2

Indexed keywords

HELICOBACTER PYLORI;

CYCLOOXYGENASE 2; INTERLEUKIN 6; MICRORNA; MIRN149 MICRORNA, HUMAN; PROSTAGLANDIN E2;

CELL LINE; ENZYMOLOGY; FIBROBLAST; GENETIC EPIGENESIS; GENETICS; HELICOBACTER PYLORI; HUMAN; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; EPIGENESIS, GENETIC; FIBROBLASTS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-6; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84928927906     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2015.51     Document Type: Article

References (66)

1. Franco OE, Shaw AK, Strand DW, Hayward SW. Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 2010; 21:33-39
2. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121:335-348
3. Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-?B-dependent manner. Cancer Cell 2010; 17:135-147
4. Swartz MA, Iida N, Roberts EW, et al. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res 2012; 72:2473-2480
5. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007; 7:139-147
6. Subbaramaiah K, Telang N, Ramonetti JT, et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996; 56:4424-4429
7. Li HJ, Reinhardt F, Herschman HR, Weinberg RA. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov 2012; 2:840-855
8. Liu CH, Chang SH, Narko K, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001; 276:18563-18569
9. Subbaramaiah K, Howe LR, Port ER, et al. HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism. Cancer Res 2006; 66:5504-5511
10. Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer 2010; 10:181-193
11. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000; 105:1589-1594
12. Ishikawa TO, Herschman HR. Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression. Carcinogenesis 2010; 31:729-736
13. Hinson RM, Williams JA, Shacter E. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci USA 1996; 93:4885-4890
14. Zhang Y, Lin JX, Vilcek J. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 1988; 263:6177-6182
15. Quante M, Tu SP, Tomita H, et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 2011; 19:257-272
16. Kinoshita H, Hirata Y, Nakagawa H, et al. Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis. PLoS One 2013; 8:e60914
17. Nagasaki T, Hara M, Nakanishi H, Takahashi H, Sato M, Takeyama H. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction. Br J Cancer 2014; 110:469-478
18. Paland N, Kamer I, Kogan-Sakin I, Madar S, Goldfinger N, Rotter V. Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in and in vitro cocultivation model of prostate cancer. Mol Cancer Res 2009; 7:1212-1223
19. Liu XH, Kirschenbaum A, Yao S, Levine AC. Interactive effect of interleukin-6 and prostaglandin E2 on Osteoclastogenesis via the OPG/RANKL/RANK system. Ann N Y Acad Sci 2006; 1068:225-233
20. Bouffi C, Bony C, Courties G, Jorgensen C, Noël D. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 2010; 5:e14247
21. Calin, GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866
22. Mitra AK, Zillhardt M, Hua Y, et al. MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov 2012; 2:1100-1108
23. Wang M, Li C, Nie H, et al. Downregulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett 2012; 586:2382-2388
24. Li P, Chen X, Su L, et al. Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP. PLoS One 2013; 8:e66782
25. Aprelikova O, Yu X, Palla J, et al. The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 2010; 9:4387-4398
26. Enkelmann A, Heinzelmann J, von Eggeling F, et al. Specific protein and miR patterns characterise tumour-associated fibroblasts in bladder cancer. J Cancer Res Clin Oncol 2011; 137:751-759
27. Zhao L, Sun Y, Hou Y, et al. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer. Int J Biochem Cell Biol 2012; 44:2051-2059
28. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6:17-32
29. Qiu W, Hu M, Sridhar A, et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 2008; 40:650-655
30. Hu M, Yao J, Cai L, et al. Distinct epigenetic changes in the stromal cells of breast cancer. Nat Genet 2005; 37:899-905
31. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6:392-401
32. Xiong Y, Fang JH, Yun JP, et al. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 2010; 51:836-845
33. Li Q, Zhang D, Wang Y, et al. MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation. Sci Rep 2013; 3:2038
34. van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008; 105:13027-13032
35. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004; 10:1507-1517
36. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420-1428
37. Cirri P, Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res 2011; 1: 482-497
38. Korkaya H, Liu S, Wicha MS. Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots. Clin Cancer Res 2011; 17:6125-6129
39. Nishikawa S, Konno M, Hamabe A, et al. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy. Int J Oncol 2013; 42:1437-1442
40. Fukuda K, Saikawa Y, Ohashi M, et al. Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol 2009; 34:1201-1207
41. Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2012; 31:1609-1622
42. Creyghton MP, Cheng AW, Welstead GG, et al. Histone H3K-27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 2010; 107:21931-21936
43. Xia D, Wang D, Kim SH, Katoh H, DuBois RN. Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nat Med 2012; 18:224-226
44. Raychaudhuri N, Douglas RS, Smith TJ. PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy. PLoS One 2010; 5:e15296
45. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Ann Rev Pathol 2006; 1:63-96
46. Akhtar M, Cheng Y, Magno RM, et al. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res 2001; 61:2399-2403
47. McCarthy CJ, Crofford LJ, Greenson J, Scheiman JM. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 1999; 94:1218-1223
48. Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12:989-995
49. Ando T, Yoshida T, Enomoto S, et al. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 2009; 124:2367-2374
50. Zabaleta J. MicroRNA: a bridge from H. pylori infection to gastritis and gastric cancer development. Front Genet 2012; 3:294
51. Liu H, Brannon AR, Reddy AR, et al. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell renal cell carcinoma. BMC Syst Biol 2010; 27:51-67
52. Pan SJ, Zhan SK, Pei BG, Sun QF, Bian LG, Sun BM. MicroRNA-149 inhibits proliferation and invasion of glioma cells via blockade of AKT1 signaling. Int J Immunopathol Pharmacol 2012; 25:871-881
53. Luo Z, Zhang L, Li Z, et al. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med Genomics 2012; 19:3-14
54. Jin L, Hu WL, Jiang CC, et al. MicroRNA-149. ∗, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci USA 2011; 108:15840-15845
55. Vrba L, Muñoz-Rodríguez JL, Stampfer MR, Futscher BW. miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS One 2013; 8:e54398
56. Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009; 15:103-113
57. Bollrath J, Phesse TJ, von Burstin VA, et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 2009; 15:91-102
58. Guan J, Zhang H, Wen Z, et al. Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells. Cancer Lett 2014; 345:132-139
59. Santini P, Politi L, Vedova PD, Scandurra R, Scotto d'Abusco A. The inflammatory circuitry of miR-149 as a pathological mechanism in osteoarthritis. Rheumatol Int 2014; 34:711-716
60. Hu S, Zhu W, Zhang LF, Pei M, Liu MF. MicroRNA-155 broadly orchestrates inflammation-induced changes of microRNA expression in breast cancer. Cell Res 2014; 24:254-257
61. Suzuki H, Maruyama R, Yamamoto E, Kai M. Epigenetic alteration and microRNA dysregulation in cancer. Front Genet 2013; 4:258
62. Wang F, Ma YL, Zhang P, et al. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. J Pathol 2013; 229:12-24
63. Wu X, Chen X, Zhou Q, et al. Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer. Cancer Lett 2013; 335:128-135
64. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997; 112:1386-1397
65. Shigematsu Y, Niwa T, Rehnberg E, et al. Interleukin-1β induced by Helicobacter pylori infection enhances mouse gastric carcinogenesis. Cancer Lett 2013; 340:141-147
66. Shimizu N, Kaminishi M, Tatematsu M, et al. Helicobacter pylori promotes development of pepsinogen-altered pyloric glands, a preneoplastic lesion of glandular stomach of BALB/c mice pretreated with N-methyl-N-nitrosourea. Cancer Lett 1998; 123:63-69